At one time, many only wished that they could know in advance what type of cancer they might have in the future. Today, with medical and technological advances, that possibility exists. Three years ago, HALO Precision Diagnostics developed a hereditary genetic testing protocol — the Halo PathWay — that has since served millions by providing early identification and detection of cancers in those with a predisposition due to a family history of cancer. With early screens and medical management, later-stage cancers that may result in death can be prevented, offering a sense of relief and reassurance.